Description
The main objective of the Action is to increase knowledge and understanding of the design and mechanisms of actions of metallo-drugs, and to use this enhanced knowledge in combination with modern genomic research to develop new classes of metallo-drugs with truly novel mechanisms of action and novel spectra of biomedical activity.
Action keywords
Parties
Action Leadership Positions
| Role | Leader |
|---|---|
| Action Chair | |
| Action Vice-Chair |
Management Committee
| Country | MC Member |
|---|---|
| Denmark | |
| Germany | |
| Serbia | |
| Serbia | |
| Slovenia | |
| Türkiye |
| Country | MC Substitute |
|---|---|
| No records found | |
Main Contacts
